期刊文献+

Ki-67和cyclin D1蛋白表达的检测对胃肠道间质瘤良恶性判断的意义 被引量:4

Significance of the Expression of Ki-67 and CyclinD1 Protein in Differentiating between Malignant and Benign Gastrointestinal Stromal Tumors
下载PDF
导出
摘要 目的 探讨Ki -67和cyclinD 1蛋白表达的检测对胃肠道间质瘤(GISTs)良恶性判断的意义。方法 应用免疫组织化学EnVision二步法检测41例GISTs组织中Ki -67和cyclinD1蛋白表达情况。结果 41例GISTs分为良性组(6例)、交界组(13例)和恶性组(2 2例) ,良性组、交界组与恶性组GISTs的Ki- 67标记指数分别为(8.5±3 .9) %、(16.8±8.6) %和(2 1.8%±8.3 ) % ,3组Ki 67标记指数比较有非常显著性差异(P <0 .0 1) ;Ki- 67标记指数与核分裂像数目、肿瘤直径及肿瘤坏死有关。良性组、交界组与恶性组GISTs的cyclinD1阳性表达率分别为16.7% (1/6)、5 3 .8% (7/13 )和68.2 % (15 /2 2 ) ,3个组cyclinD 1阳性表达率比较有显著性差异(P <0 .0 5 ) ,且良性组与交界组以及良性组与恶性组间cyclinD1阳性表达率有显著性差异(P <0 .0 5 ) ,但交界组和恶性组cyclinD1阳性表达率比较无显著性差异(P >0 .0 5 ) ;cyclinD 1阳性表达率与核分裂象数目有关,而与肿瘤直径及肿瘤坏死无关。结论 Ki- 67和cyclinD1蛋白是胃肠道间质瘤良恶性判断的有价值参考指标,结合胃肠道间质瘤形态学综合分析,更能准确客观地判断胃肠道间质瘤的良恶性。 Objective To investigate the significance of the expression of the Ki-67 and cyclin D1 protein in differentiating between the malignant and benign gastrointestinal stromal tumors(GISTs).Methods The expression of Ki-67 and cyclin D1 protein was detected by immunohistochemistry in 41 cases of GISTs.Results The Ki-67 labeling index in the benign,the borderline and the malignant GISTs was(8.5±3.9)%?(16.8±8.6)% and(21.8±8.3)%,respectively,showing a significant difference between the three groups(P<0.01).The Ki-67 labeling index was related to the tumor size,tumor necrosis and mitotic count.The positive rate of cyclin D1 protein in the benign,the borderline and the malignant GISTs was 16.7%,53.8% and 68.2% respectively.There was a significant difference in the cyclin D1 protein between the benign and the borderline GISTs,and between the benign and the malignant GISTs(P<0.05),but not between the borderline and the malignant GISTs(P<0.05).The positive rate of cyclin D1 protein was related to mitotic count,but not related to the tumor size and tumor necrosis.Conclusion The Ki-67 and cyclin D1 protein were valuable biomarkers in the differential diagnosis between the benign,the borderline and the malignant gastrointestinal stromal tumors.
机构地区 江西省肿瘤医院
出处 《实用癌症杂志》 2005年第1期53-55,61,共4页 The Practical Journal of Cancer
  • 相关文献

参考文献14

二级参考文献49

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1366
  • 2李锦清,张昌卿,张亚奇,冯凯涛,元云飞,陈敏山,郭荣平,林小军,李国辉.PCNA、p53蛋白在肝癌临床中的意义[J].癌症,1996,15(1):45-47. 被引量:22
  • 3[2]Lewin KJ, Riddell RH, Weinstein WM, et al. Gastrointestinal pathology and its clinical implications. New York:Igaku-Shoin,1992:284~341.
  • 4[3]Mazur M, Clark HB. Gastric stromal tumors: Reappraisal of histogenesis. Am J Surg Pathol, 1983,7(6):507~19.
  • 5[4]Monihan JM, Carr NJ, Sobin LH. CD34 immunoexpression in stromal tumors of the gastrointestinal tract and in mesenteric fibromatoses. Histopathology, 1994, 25(5):469~73.
  • 6[5]Miettinen M, Virolainen M, Sarlomo-Rikala M.Gastrointestinal stromal tumors: Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Pathol, 1995,19(2):207~16.
  • 7[6]Hirota S, Isozaki K, Moriiyama Y, et al. Gain-of-function mutation of C-kit in human gastrointestinal stromal tumors. Science, 1998,279(5350):577~80.
  • 8[7]Hockenbery D, Nunez G, Millimen C, et al. bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 1990,348(6229):334~6.
  • 9[8]Cunningham RE, Abbondanzo SL, Chu WS, et al. Apoptosis, bcl-2 expression, and p53 expression in gastrointestinal stromal/smooth muscle tumors. Appl Immunohistochem Mol Morphol, 2001,9(1):19~23.
  • 10[9]Panizo-Santos A, Sola I, Vega F, et al. Predicting metastatic risk of gastrointestinal stromal tumors: Role of cell proliferation and cell cycle regulatory proteins. Int J Surg Pathol, 2000,8(2):133~44.

共引文献258

同被引文献21

  • 1王振华,梁小波.胃肠道间质瘤流行病学研究进展[J].国际流行病学传染病学杂志,2013,40(3). 被引量:10
  • 2娄越亮,陈华,张燮良,战忠利.96例胃肠道间质瘤临床诊治分析[J].中华肿瘤杂志,2004,26(7):437-439. 被引量:25
  • 3徐凤琳,戚基萍,吴爱萍.胃肠道间质瘤中Bax和Ki-67的表达及其意义[J].哈尔滨医科大学学报,2005,39(2):180-182. 被引量:2
  • 4侯英勇,朱雄增.胃肠道间质瘤诊疗新进展[J].中国现代手术学杂志,2005,9(3):164-167. 被引量:11
  • 5Suster SM, Cummins R, Leader M, et al. Loss of heterozygosity of chromosome 9p and loss of p16INK4A expression are associated with malignant gastrointestinal stromal tumors[J]. Mod Pathol,2004,17(11) : 1364-1671.
  • 6Fletcher CD,Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach [J]. Hum Pathol, 2002,33 (5) : 459-465.
  • 7Dei Tos AP. The reappraisal of gastrointestinal stromal tumors: from Stout to the KIT revolution[J]. Virchows Arch, 2003,442(5) :421-428.
  • 8Fletcher CD,Berman JJ,Corless C,et al. Diagnosis of gastrointestinal stromal tutnors: a consensus approach [ J ].Hum Pathol,2002,33(5):459.
  • 9Dei Tos AP. The reappraisal of gastrointestinal stromal tumors-from Stout to the KIT revolution[J]. Virchows Arch ,2003,442(5) :421.
  • 10Suster S. Gastrointestinal Stromal Tumors[J]. Semin Diagn Pathol, 1996,13(2) :297.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部